Look up one drug

Lowest DBP recovery rule under medically necessary no-substitution claims: 6.2 Medically Necessary "No Substitution" Claims The Side Effect Reporting Form will not have to be renewed. However, the pharmacy must maintain a copy of the prescription that contains a direction that there be no substitution and the required Health Canada Side Effect Reporting Form (completed and signed by the prescriber). The prescriber must write “No Substitution” or “No Sub” on renewal or subsequent new written prescriptions, and indicate “No Substitution” on subsequent new oral prescriptions. The dispenser will be reimbursed the DBP plus a mark-up and the lesser of the posted usual and customary fee or the ODB dispensing fee minus the applicable ODB co-payment amount. Where a completed Side Effect Reporting Form is not available at the pharmacy during an inspection, the difference between the cost of the higher-cost product and the lowest DBP listed for the interchangeable category will be recovered. (ontario.ca, Revision #17; 2026-08-03 ↗) 6.2 Medically Necessary "No Substitution" Claims The Ministry will provide reimbursement of a higher-cost interchangeable product in medically necessary circumstances where a patient has experienced a significant adverse reaction with two (2) lower-cost interchangeable drug products, where available. When a prescriber identifies a patient for which it is medically necessary that a higher cost interchangeable product be provided, the prescriber must: • Complete, sign and forward to the pharmacist a copy of the Health Canada side effect reporting form for each lower-cost interchangeable drug product trialed (Side Effect Reporting Form[s]); and • Write “No Substitution” or “No Sub” on a written prescription or indicate “No Substitution” to the pharmacist in the case of a verbal prescription. The prescriber should keep a copy of the completed form in the patient’s record for future use and reference. In the case of a written prescription, when the pharmacist or dispensing physician receives a prescription with the written notation “No Substitution” or “No Sub”, reimbursement will be provided for the higher-cost interchangeable product only if the prescription is accompanied by a completed Health Canada Side Effect Reporting Form for each of the lower-cost interchangeable drug products trialed. This form must be completely filled out noting the details of the adverse reaction and signed by the prescriber. In the case of a verbal prescription, the prescriber must satisfy the operator of the pharmacy or dispensing physician that a completed Health Canada Side Effect Reporting Form for each of the lower-cost interchangeable drug products trialed has been completed and signed by the prescriber. A written record of this verbal prescription and the completed Health Canada Side Effect Reporting Form must be received by the pharmacy prior to claim submission. Upon receipt, the pharmacist must: • Fax, submit online or mail the completed and signed form to Health Canada’s Canada Vigilance Program; and • Retain his or her copy of the completed and signed Side Effect Reporting Form. (ontario.ca, Revision #17; 2026-08-03 ↗)

Jamp-Escitalopram · DIN 02429799 Manufacturer: Jamp Pharma Corporation; listing date 2014-11-27 Health Canada: Marketed since 2023-04-26 · brand ESCITALOPRAM · ATC N06AB10 ESCITALOPRAM · form Tablet · route Oral · ingredients ESCITALOPRAM (ESCITALOPRAM OXALATE) 20 MG · company Jamp pharma corporation · schedule Prescription

DIN 02429799: Jamp-Escitalopram Raw flags: sec3=Y Item: 281604119; group id 460; item number 1153; lccId None; manufacturer id JPC Source form: Tab; strength: 20mg Recorded listing: General benefit Source prices (unrounded): $0.3310; ministry $0.3310 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02429799 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=91423

Interchangeable products

Ach-Escitalopram · DIN 02434660 · $0.3310 Apo-Escitalopram · DIN 02295024 · $0.3310 Auro-Escitalopram · DIN 02397374 · $0.3310 Cipralex · DIN 02263254 · $0.3310 Escitalopram · DIN 02429047 · $0.3310 Escitalopram · DIN 02430126 · $0.3310 Jamp Escitalopram · DIN 02508907 · $0.3310 M-Escitalopram · DIN 02471426 · $0.3310 Mar-Escitalopram · DIN 02423502 · $0.3310 Mint-Escitalopram · DIN 02407434 · $0.3310 Mylan-Escitalopram · DIN 02309475 · $0.3310 NRA-Escitalopram · DIN 02476878 · $0.3310 Natco-Escitalopram · DIN 02554933 · $0.3310 PMS-Escitalopram · DIN 02469251 · $0.3310 Ran-Escitalopram · DIN 02385503 · $0.3310 Sandoz Escitalopram · DIN 02364085 · $0.3310 Teva-Escitalopram · DIN 02318202 · $0.3310

Shortage status: not checked (no credentials)